During the course of our ongoing screening for novel biologically active secondary metabolites, the rare Actinobacterium, sp. 1808210CR was found to produce five unprecedented -carboline derivatives, nonocarbolines A-E (). Their structures were elucidated from high-resolution mass spectrometry, 1D and 2D nuclear magnetic resonance spectroscopy, and the absolute configuration of was determined by using the modified Mosher method. Nonocarboline B () displayed moderate antifungal activity against , while nonocarboline D () exhibited significant cytotoxic activity against the human lung carcinoma cell line A-549 with the IC value of 1.7 µM.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148486 | PMC |
| http://dx.doi.org/10.3390/antibiotics9030126 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Nonocarbolines A-E, -Carboline Antibiotics Produced by the Rare Actinobacterium sp. from Indonesia.
Antibiotics (Basel)
March 2020
Department Microbial Drugs, Helmholtz Centre for Infection Research GmbH (HZI), Inhoffenstrasse 7, 38124 Braunschweig, Germany.
During the course of our ongoing screening for novel biologically active secondary metabolites, the rare Actinobacterium, sp. 1808210CR was found to produce five unprecedented -carboline derivatives, nonocarbolines A-E (). Their structures were elucidated from high-resolution mass spectrometry, 1D and 2D nuclear magnetic resonance spectroscopy, and the absolute configuration of was determined by using the modified Mosher method.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!